نيتازوكسانيد

نيتازوكسانيد
يعالج	داء خفيات الأبواغ، وداء الجيارديات[1][2]
اعتبارات علاجية
معرّفات
CAS	55981-09-4
ك ع ت	P01AX11
بوب كيم	41684
ECHA InfoCard ID	100.054.465
درغ بنك	00507
كيم سبايدر	38037
المكون الفريد	SOA12P041N
كيوتو	D02486
ChEMBL	CHEMBL1401
بيانات كيميائية
الصيغة الكيميائية	C₁₂H₉N₃O₅S[3]
	مواصفات الإدخال النصي المبسط للجزيئات
	المعرف الكيميائي الدولي

نيتازوكسانيد (بالإنجليزية: Nitazoxanide)‏ هو دواء يُستعمل في علاج:[4][5][6]

دوره

يلعب هذا الدواء دورًا في علاج الأمراض كونه:[8]

المراجع

مُعرِّف المُصطلَحات المرجعيَّة في ملف المخدرات الوطني (NDF-RT): https://bioportal.bioontology.org/ontologies/NDFRT?p=classes&conceptid=N0000148784 — تاريخ الاطلاع: 13 ديسمبر 2016
المؤلف: Lyne Jossé و Anastasios D Tsaousis — العنوان : Past and future trends of Cryptosporidium in vitro research — نشر في: Experimental Parasitology — المجلد: 196 — الصفحة: 28-37 — https://dx.doi.org/10.1016/J.EXPPARA.2018.12.001 — https://pubmed.ncbi.nlm.nih.gov/30521793 — https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333944 — مُعرِّف المُصطلَحات المرجعيَّة في ملف المخدرات الوطني (NDF-RT): https://bioportal.bioontology.org/ontologies/NDFRT?p=classes&conceptid=N0000148784 — الرخصة: رخصة المشاع الإبداعي الدولية المُلزِمة بالنسب لمؤلِّف العمل 4.0
العنوان : NITAZOXANIDE — مُعرِّف "بَب كِيم" (PubChem CID): https://pubchem.ncbi.nlm.nih.gov/compound/41684 — تاريخ الاطلاع: 19 نوفمبر 2016 — الرخصة: محتوى حر
Rossignol JF (أكتوبر 2014)، "Nitazoxanide: a first-in-class broad-spectrum antiviral agent"، Antiviral Res.، 110: 94–103، doi:10.1016/j.antiviral.2014.07.014، PMID 25108173، Originally developed and commercialized as an antiprotozoal agent, nitazoxanide was later identified as a first-in-class broad-spectrum antiviral drug and has been repurposed for the treatment of influenza. ... From a chemical perspective, nitazoxanide is the scaffold for a new class of drugs called thiazolides. These small-molecule drugs target host-regulated processes involved in viral replication. ... A new dosage formulation of nitazoxanide is presently undergoing global Phase 3 clinical development for the treatment of influenza. Nitazoxanide inhibits a broad range of influenza A and B viruses including influenza A(pH1N1) and the avian A(H7N9) as well as viruses that are resistant to neuraminidase inhibitors. ... Nitazoxanide also inhibits the replication of a broad range of other RNA and DNA viruses including respiratory syncytial virus, parainfluenza, coronavirus, rotavirus, norovirus, hepatitis B, hepatitis C, dengue, yellow fever, Japanese encephalitis virus and human immunodeficiency virus in cell culture assays. Clinical trials have indicated a potential role for thiazolides in treating rotavirus and norovirus gastroenteritis and chronic hepatitis B and chronic hepatitis C. Ongoing and future clinical development is focused on viral respiratory infections, viral gastroenteritis and emerging infections such as dengue fever.
Di Santo N, Ehrisman J (2013)، "Research perspective: potential role of nitazoxanide in ovarian cancer treatment. Old drug, new purpose?"، Cancers (Basel)، 5 (3): 1163–1176، doi:10.3390/cancers5031163، PMC 3795384، PMID 24202339، Nitazoxanide [NTZ: 2-acetyloxy-N-(5-nitro-2-thiazolyl)benzamide] is a thiazolide antiparasitic agent with excellent activity against a wide variety of protozoa and helminths. ... Nitazoxanide (NTZ) is a main compound of a class of broad-spectrum anti-parasitic compounds named thiazolides. It is composed of a nitrothiazole-ring and a salicylic acid moiety which are linked together by an amide bond ... NTZ is generally well tolerated, and no significant adverse events have been noted in human trials [13]. ... In vitro, NTZ and tizoxanide function against a wide range of organisms, including the protozoal species Blastocystis hominis, C. parvum, Entamoeba histolytica, G. lamblia and Trichomonas vaginalis [13]
White CA (2004)، "Nitazoxanide: a new broad spectrum antiparasitic agent"، Expert Rev Anti Infect Ther، 2 (1): 43–9، doi:10.1586/14787210.2.1.43، PMID 15482170.
"معرف المصطلحات المرجعية بملف المخدرات الوطني"، المصطلحات المرجعية بملف العقاقير الوطني، مؤرشف من الأصل في 30 مايو 2019، اطلع عليه بتاريخ 13 ديسمبر 2016.
"معرف المصطلحات المرجعية بملف المخدرات الوطني"، المصطلحات المرجعية بملف العقاقير الوطني، مؤرشف من الأصل في 30 مايو 2019، اطلع عليه بتاريخ 5 مارس 2018.

إخلاء مسؤولية طبية

بوابة البرازيل
بوابة تمريض
بوابة صيدلة
بوابة طب

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[442cd1cd85f7ac98287722ce8260e3875ea7a05c-1] مُعرِّف المُصطلَحات المرجعيَّة في ملف المخدرات الوطني (NDF-RT): https://bioportal.bioontology.org/ontologies/NDFRT?p=classes&conceptid=N0000148784 — تاريخ الاطلاع: 13 ديسمبر 2016

[19166867a096691c8a1beeb738d6b1aeea4b76db-2] المؤلف: Lyne Jossé و Anastasios D Tsaousis — العنوان : Past and future trends of Cryptosporidium in vitro research — نشر في: Experimental Parasitology — المجلد: 196 — الصفحة: 28-37 — https://dx.doi.org/10.1016/J.EXPPARA.2018.12.001 — https://pubmed.ncbi.nlm.nih.gov/30521793 — https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333944 — مُعرِّف المُصطلَحات المرجعيَّة في ملف المخدرات الوطني (NDF-RT): https://bioportal.bioontology.org/ontologies/NDFRT?p=classes&conceptid=N0000148784 — الرخصة: رخصة المشاع الإبداعي الدولية المُلزِمة بالنسب لمؤلِّف العمل 4.0

[1fb9e65d5494238ec742f26a8186f39e60fb81e0-3] العنوان : NITAZOXANIDE — مُعرِّف "بَب كِيم" (PubChem CID): https://pubchem.ncbi.nlm.nih.gov/compound/41684 — تاريخ الاطلاع: 19 نوفمبر 2016 — الرخصة: محتوى حر

[Broad-spectrum_antiviral_review-4] Rossignol JF (أكتوبر 2014)، "Nitazoxanide: a first-in-class broad-spectrum antiviral agent"، Antiviral Res.، 110: 94–103، doi:10.1016/j.antiviral.2014.07.014، PMID 25108173، Originally developed and commercialized as an antiprotozoal agent, nitazoxanide was later identified as a first-in-class broad-spectrum antiviral drug and has been repurposed for the treatment of influenza. ... From a chemical perspective, nitazoxanide is the scaffold for a new class of drugs called thiazolides. These small-molecule drugs target host-regulated processes involved in viral replication. ... A new dosage formulation of nitazoxanide is presently undergoing global Phase 3 clinical development for the treatment of influenza. Nitazoxanide inhibits a broad range of influenza A and B viruses including influenza A(pH1N1) and the avian A(H7N9) as well as viruses that are resistant to neuraminidase inhibitors. ... Nitazoxanide also inhibits the replication of a broad range of other RNA and DNA viruses including respiratory syncytial virus, parainfluenza, coronavirus, rotavirus, norovirus, hepatitis B, hepatitis C, dengue, yellow fever, Japanese encephalitis virus and human immunodeficiency virus in cell culture assays. Clinical trials have indicated a potential role for thiazolides in treating rotavirus and norovirus gastroenteritis and chronic hepatitis B and chronic hepatitis C. Ongoing and future clinical development is focused on viral respiratory infections, viral gastroenteritis and emerging infections such as dengue fever.

[Thiazolides-5] Di Santo N, Ehrisman J (2013)، "Research perspective: potential role of nitazoxanide in ovarian cancer treatment. Old drug, new purpose?"، Cancers (Basel)، 5 (3): 1163–1176، doi:10.3390/cancers5031163، PMC 3795384، PMID 24202339، Nitazoxanide [NTZ: 2-acetyloxy-N-(5-nitro-2-thiazolyl)benzamide] is a thiazolide antiparasitic agent with excellent activity against a wide variety of protozoa and helminths. ... Nitazoxanide (NTZ) is a main compound of a class of broad-spectrum anti-parasitic compounds named thiazolides. It is composed of a nitrothiazole-ring and a salicylic acid moiety which are linked together by an amide bond ... NTZ is generally well tolerated, and no significant adverse events have been noted in human trials [13]. ... In vitro, NTZ and tizoxanide function against a wide range of organisms, including the protozoal species Blastocystis hominis, C. parvum, Entamoeba histolytica, G. lamblia and Trichomonas vaginalis [13]

[Nitazoxanide:_Broad-spectrum_antiparasitic-6] White CA (2004)، "Nitazoxanide: a new broad spectrum antiparasitic agent"، Expert Rev Anti Infect Ther، 2 (1): 43–9، doi:10.1586/14787210.2.1.43، PMID 15482170.

[مولد_تلقائيا1-7] "معرف المصطلحات المرجعية بملف المخدرات الوطني"، المصطلحات المرجعية بملف العقاقير الوطني، مؤرشف من الأصل في 30 مايو 2019، اطلع عليه بتاريخ 13 ديسمبر 2016.

[8] "معرف المصطلحات المرجعية بملف المخدرات الوطني"، المصطلحات المرجعية بملف العقاقير الوطني، مؤرشف من الأصل في 30 مايو 2019، اطلع عليه بتاريخ 5 مارس 2018.